Literature DB >> 909060

Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.

P A Friedman, F Roch-Ramel.   

Abstract

Renal hemodynamic and natriuretic effects of bumetanide and furosemide were studied by clearance and micropuncture methods in cats. Furosemide (0.04-5.0 mg/kg i.v.) effects increased with increasing doses up to a maximal fractional sodium (FEna) and water (V/GFR) excretion of 23%. GFR and superficial single nephron GFR remained constant. Renal blood flow (RBF) increased up to 45% over control. A preferential increase in outer cortical RBF occurred at 5.0 mg/kg. Bumetanide (0.001-0.14 mg/kg i.v.) raised FEna and V/GFR maximally by 26%. Only at a supramaximal dose (0.69 mg/kg) did bumetanide raise RBF and depress filtration fraction. Probenecid (50 mg/kg i.v.) failed to block the natriuretic effect of bumetanide (0.025 microgram/kg-min) when infused into one renal artery but abolished the natriuretic action of furosemide (1.0 microgram/kg-min). Probenecid failed to displace the dose-response curve for bumetanide.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 909060

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Comparison of the acute vascular effects of frusemide and bumetanide.

Authors:  G D Johnston; D P Nicholls; G B Kondowe; M B Finch
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

2.  Micropuncture study of fluid handling in the cat kidney.

Authors:  P A Friedman; F Roch-Ramel
Journal:  Pflugers Arch       Date:  1977       Impact factor: 3.657

3.  Application of effect-compartment model to bumetanide-indomethacin interaction in dogs.

Authors:  D E Smith; H S Lau; J L Fox
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

Review 4.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

5.  Studies with the optically active isomers of the new diuretic drug ozolinone. I. Differences in stereoselectivity of the renal target structures of ozolinone.

Authors:  J Greven; W Defrain; K Glaser; K Meywald; O Heidenreich
Journal:  Pflugers Arch       Date:  1980-03       Impact factor: 3.657

6.  Determinants of bumetanide response in the dog: effect of probenecid.

Authors:  D E Smith; H S Lau
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

7.  The influence of co-administered organic acids on the kinetics and dynamics of frusemide.

Authors:  D K Sommers; E C Meyer; J Moncrieff
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

8.  Probenecid potentiates the hyperglycaemic effect but reduces the diuretic effect of frusemide in mice.

Authors:  P E Sandström
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

Review 9.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

10.  Comparison of the acute renal and peripheral vascular responses to frusemide and bumetanide at low and high dose.

Authors:  A P Passmore; E M Whitehead; G D Johnston
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.